Related Experiment Video
Updated: Jul 12, 2025

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
Published on: May 26, 2021
Clonal hematopoiesis and inflammation: A review of mechanisms and clinical implications
Daniel I Nathan1, Max Dougherty1, Manasa Bhatta2
1Tisch Cancer Institute, Division of Hematology and Medical Oncology, The Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Insights
Clonal hematopoiesis (CH), driven by mutations in hematopoietic stem cells, is linked to aging and inflammation. Understanding this link may reveal new therapies for myeloid malignancy.
Area of Science:
- Hematology
- Immunology
- Gerontology
Background:
- Clonal hematopoiesis (CH) involves somatic mutations in hematopoietic stem and progenitor cells (HSPC).
- CH is associated with aging, increased risk of hematologic malignancy, cardiovascular disease, and inflammatory conditions.
- The interplay between CH, aging, and inflammation is a growing area of research.
Purpose of the Study:
- To review the complex relationship between inflammation and CH.
- To summarize current understanding of how inflammation influences CH and vice versa.
- To highlight the implications for preventing myeloid malignancy.
Main Methods:
- This is a review article.
- Synthesizes findings from observational and experimental studies.
- Focuses on the pathophysiologic and clinical aspects of the CH-inflammation interaction.
Main Results:
- CH may be a common factor in age-related inflammatory diseases.
- Inflammation can promote the development and expansion of CH clones.
- The bidirectional relationship between CH and inflammation is central to disease pathogenesis.
Conclusions:
- The relationship between inflammation and CH is critical for understanding aging-related diseases.
- Targeting this relationship may offer therapeutic strategies to prevent myeloid malignancy progression.
- Further research is needed to fully elucidate these complex interactions.
Abstract:
Clonal hematopoiesis (CH) is defined by the presence of somatic mutations in hematopoietic stem and progenitor cells (HSPC). CH is associated primarily with advancing age and confers an elevated risk of progression to overt hematologic malignancy and cardiovascular disease. Increasingly, CH is associated with a wide range of diseases driven by, and sequelae of, inflammation. Accordingly, there is great interest in better understanding the pathophysiologic and clinical relationship between CH, aging, and disease. Both observational and experimental findings support the concept that CH is a potential common denominator in the inflammatory outcomes of aging. However, there is also evidence that local and systemic inflammatory states promote the growth and select for CH clones. In this review, we aim to provide an up-to-date summary of the nature of the relationship between inflammation and CH, which is central to unlocking potential therapeutic opportunities to prevent progression to myeloid malignancy.
More Related Videos
08:17A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research
Published on: August 15, 2019
12:03Phenotypic Analysis and Isolation of Murine Hematopoietic Stem Cells and Lineage-committed Progenitors
Published on: July 8, 2012
Related Concept Videos
Regulation of Hematopoietic Stem Cells
Hematopoiesis
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Overview of Hematopoiesis
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...